New target for CAR T cells in solid tumors: Chimeric antigen receptor T cells that target OR2H1 inhibit lung and ovarian tumor growth in mice
Chimeric antigen receptor T-cell therapy, or CAR T, has made a big impact on the treatment of certain blood cancers, allowing patients with relapsed/refractory disease to live longer, healthier lives.…